1. Treatment-related costs of childhood epilepsy in mainland China: a preliminary study in a tertiary pediatric epilepsy center;Sang;J Child Neurol,2019
2. Development of perampanel in epilepsy;Satlin;Acta Neurol Scand,2013
3. The neurobiology of antiepileptic drugs;Rogawski;Nat Rev Neurosci,2004
4. European Medicines Agency. Fycompa (INN, perampanel): summary of product characteristics. [cited 2019 February 11]; Available from: http://www.ema.europa.eu/documents/product-information/fycompa-epar-product-information_en.pdf.
5. Comparison of the effectiveness and tolerability of perampanel and brivaracetam: a real-world, observational, retrospective study;Liguori;Epileptic Disord,2020